442 related articles for article (PubMed ID: 29128108)
1. Rebalancing the Addicted Brain: Oxytocin Interference with the Neural Substrates of Addiction.
Bowen MT; Neumann ID
Trends Neurosci; 2017 Dec; 40(12):691-708. PubMed ID: 29128108
[TBL] [Abstract][Full Text] [Related]
2. The Multidimensional Therapeutic Potential of Targeting the Brain Oxytocin System for the Treatment of Substance Use Disorders.
Bowen MT; Neumann ID
Curr Top Behav Neurosci; 2018; 35():269-287. PubMed ID: 28942596
[TBL] [Abstract][Full Text] [Related]
3. Targeting the Oxytocin System to Treat Addictive Disorders: Rationale and Progress to Date.
Lee MR; Rohn MC; Tanda G; Leggio L
CNS Drugs; 2016 Feb; 30(2):109-23. PubMed ID: 26932552
[TBL] [Abstract][Full Text] [Related]
4. The role of oxytocin in alcohol and drug abuse.
King CE; Gano A; Becker HC
Brain Res; 2020 Jun; 1736():146761. PubMed ID: 32142721
[TBL] [Abstract][Full Text] [Related]
5. From ultrasocial to antisocial: a role for oxytocin in the acute reinforcing effects and long-term adverse consequences of drug use?
McGregor IS; Callaghan PD; Hunt GE
Br J Pharmacol; 2008 May; 154(2):358-68. PubMed ID: 18475254
[TBL] [Abstract][Full Text] [Related]
6. Oxytocin and Rodent Models of Addiction.
Leong KC; Cox S; King C; Becker H; Reichel CM
Int Rev Neurobiol; 2018; 140():201-247. PubMed ID: 30193705
[TBL] [Abstract][Full Text] [Related]
7. Oxytocin and Addiction: Potential Glutamatergic Mechanisms.
Sundar M; Patel D; Young Z; Leong KC
Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33673694
[TBL] [Abstract][Full Text] [Related]
8. Oxytocin Signaling as a Target to Block Social Defeat-Induced Increases in Drug Abuse Reward.
Ferrer-Pérez C; Reguilón MD; Miñarro J; Rodríguez-Arias M
Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33673448
[TBL] [Abstract][Full Text] [Related]
9. Drug dependence and addiction: neural substrates.
Self D
Am J Psychiatry; 2004 Feb; 161(2):223. PubMed ID: 14754767
[No Abstract] [Full Text] [Related]
10. Oxytocin in learning and addiction: From early discoveries to the present.
Sarnyai Z; Kovács GL
Pharmacol Biochem Behav; 2014 Apr; 119():3-9. PubMed ID: 24280016
[TBL] [Abstract][Full Text] [Related]
11. Oxytocin signaling in the treatment of drug addiction: Therapeutic opportunities and challenges.
Che X; Cai J; Liu Y; Xu T; Yang J; Wu C
Pharmacol Ther; 2021 Jul; 223():107820. PubMed ID: 33600854
[TBL] [Abstract][Full Text] [Related]
12. Oxytocin and addiction: a review.
Kovács GL; Sarnyai Z; Szabó G
Psychoneuroendocrinology; 1998 Nov; 23(8):945-62. PubMed ID: 9924746
[TBL] [Abstract][Full Text] [Related]
13. New approach to the neurobiological mechanisms of addiction.
Fürst Z; Riba P; Al-Khrasani M
Neuropsychopharmacol Hung; 2013 Dec; 15(4):189-205. PubMed ID: 24380960
[TBL] [Abstract][Full Text] [Related]
14. Sigma Receptors and Substance Use Disorders.
Sabino V; Hicks C; Cottone P
Adv Exp Med Biol; 2017; 964():177-199. PubMed ID: 28315272
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic pharmacotherapy for substance use disorder.
Sartor GC
Biochem Pharmacol; 2019 Oct; 168():269-274. PubMed ID: 31306644
[TBL] [Abstract][Full Text] [Related]
16. Early adverse experience and substance addiction: dopamine, oxytocin, and glucocorticoid pathways.
Kim S; Kwok S; Mayes LC; Potenza MN; Rutherford HJV; Strathearn L
Ann N Y Acad Sci; 2017 Apr; 1394(1):74-91. PubMed ID: 27508337
[TBL] [Abstract][Full Text] [Related]
17. Health for life. Addiction: how to break the chain.
Miller MC
Newsweek; 2005 Dec; 146(24):58. PubMed ID: 16375164
[No Abstract] [Full Text] [Related]
18. Drugs, sleep, and the addicted brain.
Valentino RJ; Volkow ND
Neuropsychopharmacology; 2020 Jan; 45(1):3-5. PubMed ID: 31311031
[No Abstract] [Full Text] [Related]
19. Focusing on the Opioid System for Addiction Biomarker Discovery.
Belzeaux R; Lalanne L; Kieffer BL; Lutz PE
Trends Mol Med; 2018 Feb; 24(2):206-220. PubMed ID: 29396147
[TBL] [Abstract][Full Text] [Related]
20. A brief history of oxytocin and its role in modulating psychostimulant effects.
Carson DS; Guastella AJ; Taylor ER; McGregor IS
J Psychopharmacol; 2013 Mar; 27(3):231-47. PubMed ID: 23348754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
